Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Cash from Financing Activities: 2024-2025

Historic Cash from Financing Activities for Pyxis Oncology (PYXS) over the last 1 years, with Sep 2025 value amounting to -$8,000.

  • Pyxis Oncology's Cash from Financing Activities fell 100.48% to -$8,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year change of. This contributed to the annual value of $59.3 million for FY2024, which is 900.61% up from last year.
  • As of Q3 2025, Pyxis Oncology's Cash from Financing Activities stood at -$8,000, which was down 116.00% from $50,000 recorded in Q4 2024.
  • In the past 5 years, Pyxis Oncology's Cash from Financing Activities registered a high of $57.5 million during Q1 2024, and its lowest value of -$8,000 during Q3 2025.
  • Over the past 2 years, Pyxis Oncology's median Cash from Financing Activities value was $110,000 (recorded in 2024), while the average stood at $11.9 million.
  • Data for Pyxis Oncology's Cash from Financing Activities shows a maximum YoY tumbled of 100.48% (in 2025) over the last 5 years.
  • Over the past 2 years, Pyxis Oncology's Cash from Financing Activities (Quarterly) stood at $50,000 in 2024, then slumped by 100.48% to -$8,000 in 2025.
  • Its Cash from Financing Activities was -$8,000 in Q3 2025, compared to $50,000 in Q4 2024 and $1.7 million in Q3 2024.